| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Jun 20, 2024 | Traws Pharma, Inc. | CFO | Sell | 27.5 | -2,221 | -5.35% | ✗ | $1K |
| Mar 13, 2024 | Mar 15, 2024 | Traws Pharma, Inc. | CFO | Sell | 27.5 | -2,591 | -6.72% | ✗ | $2.3K |
| Feb 7, 2024 | Feb 9, 2024 | Traws Pharma, Inc. | CFO | Sell | 27.5 | -2,443 | -7.55% | ✗ | $1.6K |
| Aug 2, 2023 | Aug 4, 2023 | Traws Pharma, Inc. | CFO | Sell | 27.5 | -1,422 | -5.29% | ✗ | $1.5K |
| Jun 12, 2023 | Jun 13, 2023 | Traws Pharma, Inc. | CFO | Sell | 27.5 | -1,575 | -6.65% | ✗ | $1.8K |
| Feb 7, 2023 | Feb 8, 2023 | Traws Pharma, Inc. | CFO | Sell | 27.5 | -1,785 | -8.94% | ✗ | $2.4K |
| Aug 2, 2022 | Aug 4, 2022 | Traws Pharma, Inc. | CFO | Sell | 27.5 | -1,355 | -9.39% | ✗ | $1.8K |
| Feb 16, 2021 | Feb 17, 2021 | Traws Pharma, Inc. | CFO | Buy | 91.3 | +15,000 | 11.52% | ✗ | $15K |
| Nov 25, 2020 | Nov 30, 2020 | Traws Pharma, Inc. | CFO | Buy | 90.0 | +21,369 | 19.63% | ✗ | $5.6K |
| May 19, 2020 | May 20, 2020 | Traws Pharma, Inc. | CFO | Buy | 90.0 | +21,000 | 23.91% | ✗ | $7.6K |
| Nov 25, 2019 | Nov 26, 2019 | Traws Pharma, Inc. | CFO | Buy | 91.3 | +87,500 | 25436.05% | ✗ | $17.5K |
| Apr 26, 2017 | Apr 28, 2017 | Traws Pharma, Inc. | CFO | Buy | 90.0 | +1,429 | 38.35% | ✗ | $3K |